5 Things Your Taxes Bought for the Pentagon in February
How to Get Top Dollar Selling Your Wedding Dress Online
How Men Buy Groceries - and How Stores Are Taking Note
Cap'n Crunch Enlisted to Boost Taco Bell's Breakfast Sales
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.